Disclosure Of Fair Value Measurement [Text Block]

BerGenBio - Filing #2542730

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
174,335,000 NOK
166,706,000 NOK
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
46,859,000 NOK
78,208,000 NOK
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
854,000 NOK
268,869,000 NOK
189,234,000 NOK
46,987,000 NOK
127,476,000 NOK
88,498,000 NOK
35,780,000 NOK
0 NOK
8,866,000 NOK
43,852,000 NOK
0 NOK
384,426,000 NOK
40,386,000 NOK
335,195,000 NOK
8,846,000 NOK
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.